These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9202670)

  • 1. Activation of Raf-1 in human pancreatic adenocarcinoma.
    Berger DH; Jardines LA; Chang H; Ruggeri B
    J Surg Res; 1997 Apr; 69(1):199-204. PubMed ID: 9202670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration.
    Giehl K; Skripczynski B; Mansard A; Menke A; Gierschik P
    Oncogene; 2000 Jun; 19(25):2930-42. PubMed ID: 10871844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma.
    Oka H; Chatani Y; Hoshino R; Ogawa O; Kakehi Y; Terachi T; Okada Y; Kawaichi M; Kohno M; Yoshida O
    Cancer Res; 1995 Sep; 55(18):4182-7. PubMed ID: 7664295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F; Bonnec G; Tardivel A; Boujard D
    Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
    Jin K; Park S; Ewton DZ; Friedman E
    Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
    Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ
    Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
    J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
    Guha S; Lunn JA; Santiskulvong C; Rozengurt E
    Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling.
    Villalonga P; López-Alcalá C; Bosch M; Chiloeches A; Rocamora N; Gil J; Marais R; Marshall CJ; Bachs O; Agell N
    Mol Cell Biol; 2001 Nov; 21(21):7345-54. PubMed ID: 11585916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src tyrosine kinase mediates stimulation of Raf-1 and mitogen-activated protein kinase by the tumor promoter thapsigargin.
    Chao TS; Abe M; Hershenson MB; Gomes I; Rosner MR
    Cancer Res; 1997 Aug; 57(15):3168-73. PubMed ID: 9242445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
    Jamieson S; Alexiadis M; Fuller PJ
    Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors.
    Hoshino R; Chatani Y; Yamori T; Tsuruo T; Oka H; Yoshida O; Shimada Y; Ari-i S; Wada H; Fujimoto J; Kohno M
    Oncogene; 1999 Jan; 18(3):813-22. PubMed ID: 9989833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential involvement of H- and K-Ras in Raf-1 activation determines the role of calmodulin in MAPK signaling.
    Moretó J; Vidal-Quadras M; Pol A; Santos E; Grewal T; Enrich C; Tebar F
    Cell Signal; 2009 Dec; 21(12):1827-36. PubMed ID: 19666110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy.
    Fleming JB; Shen GL; Holloway SE; Davis M; Brekken RA
    Mol Cancer Res; 2005 Jul; 3(7):413-23. PubMed ID: 16046552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI-3-kinase is an essential anti-apoptotic effector in the proliferative response of primary human epithelial cells to mutant RAS.
    Gire V; Marshall C; Wynford-Thomas D
    Oncogene; 2000 May; 19(19):2269-76. PubMed ID: 10822377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1.
    Bosch E; Cherwinski H; Peterson D; McMahon M
    Oncogene; 1997 Aug; 15(9):1021-33. PubMed ID: 9285556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines.
    Patton SE; Martin ML; Nelsen LL; Fang X; Mills GB; Bast RC; Ostrowski MC
    Cancer Res; 1998 May; 58(10):2253-9. PubMed ID: 9605774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.